Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 591,933 |
|
|||||
| News | - | ||||||
| Day High | 65.54 | Low High |
|||||
| Day Low | 62.59 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Lantheus Holdings Inc | LNTH | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 1.34 | 2.12% | 64.41 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 63.02 | 62.59 | 65.54 | 64.41 | 63.07 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 16,204 | 591,933 | $ 64.64 | $ 38,260,475 | - | 50.20 - 100.8505 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 17:44:29 | 40 | $ 64.40 | USD |
Lantheus Holdings Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 4.41B | 68.53M | - | 1.3B | 326.66M | 4.77 | 13.51 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Lantheus News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical LNTH Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 59.94 | 65.54 | 59.5635 | 62.56 | 765,780 | 4.47 | 7.46% |
| 1 Month | 59.43 | 65.54 | 57.92 | 60.85 | 728,847 | 4.98 | 8.38% |
| 3 Months | 53.68 | 69.73 | 51.79 | 60.08 | 872,079 | 10.73 | 19.99% |
| 6 Months | 68.94 | 79.20 | 50.20 | 61.16 | 1,107,472 | -4.53 | -6.57% |
| 1 Year | 90.65 | 100.8505 | 50.20 | 70.04 | 1,081,267 | -26.24 | -28.95% |
| 3 Years | 21.97 | 100.8505 | 19.301 | 60.88 | 982,083 | 42.44 | 193.17% |
| 5 Years | 24.30 | 100.8505 | 8.67 | 50.30 | 772,876 | 40.11 | 165.06% |
Lantheus Description
| Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its imaging products and agents assist clinicians in the diagnosis and treatment of cardiovascular and other diseases. Its agents are typically non-radioactive compounds that are used in diagnostic procedures, such as cardiac ultrasounds, or echocardiograms, x-ray imaging used by physicians to progress the clarity of the diagnostic image. Its portfolio of imaging products includes medical radiopharmaceuticals such as DEFINITY, TechneLite, Xenon Xe 133 Gas, Cardiolite, and Neurolite. Its revenue is generated from the sales of diagnostic imaging agents to wholesalers, distributors radiopharmacy and directly to hospitals and clinics predominantly in the United States. |
